Trials / Completed
CompletedNCT00370032
Study to Assess the Effect Of Alosetron On Mucosal Blood Flow
A Randomize, Placebo-controlled, Crossover Study to Measure the Effect of Alosetron on Mucosal Blood Flow in Female Healthy Volunteers and Diarrhea-predominant IBS Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 49 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
This study will look at colonic mucosal blood flow in subjects who have taken alosetron vs placebo and healthy volunteers vs diarrhea-predominant Irritable Bowel Syndrome (d-IBS) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alosetron |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2006-08-30
- Last updated
- 2015-05-18
- Results posted
- 2009-04-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00370032. Inclusion in this directory is not an endorsement.